68 units of semaglutide 1.7 mg (68 units) once weekly injections Tirzepatide and Semaglutide key differences,

The future market may not be people on GLP-1s

The idea is that stacking two different satiety pathways gives better results than either alone

Tirzepatide: A GIP/GLP-1 Dual Agonist for MASH. The New England Journal of Medicine , 2024, www.nejm.org/doi/full/10.1056/NEJMoa2401943

"BPC 157 and standard angiogenic growth factors: Gastrointestinal tract healing, lessons learned from tendon, ligament, muscle and bone healing." Current Pharmaceutical Design

Mone, Pasquale et al

Intermittent fasting, Paleolithic, or Mediterranean diets in the real world: exploratory secondary analyses of a weight-loss trial that included choice of diet and exercise